Skip to content

Effect of Carbonated Soft Drinks on the Body Weight

Effect of Carbonated Soft Drinks on Body Weight, Fat Distribution and Metabolic Risk Factors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00777647
Enrollment
60
Registered
2008-10-22
Start date
2008-05-31
Completion date
2010-12-31
Last updated
2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Habits, Metabolic; Complications, Obesity

Brief summary

Compared to solid foods, the nutritional energy of drinks may bypass the appetite regulation leading to obesity development. Although drinks sweetened with aspartame are available the anticipated positive effect of these drinks on obesity development has not been convincing. However, the mechanisms linking drinks intake to obesity are yet to be clarified. The investigators aim is to investigate the long-term effects of intake of soft drinks, milk and water. The study is a parallel, intervention trial with 80 overweight, healthy volunteers. They will be randomly selected to drink one liter a day of one of the four drinks for six months. The objectives are changes in numerous circulating metabolic risk factors, changes in body weight, anthropometric data and fat distribution (measured by DEXA, MRI and MR-spectroscopy). The investigators expect to clarify the mechanisms linking drinking habits to obesity development and provide scientifically based nutritional guidelines.

Interventions

One litre a day for six months.

One litre a day for six months.

One litre a day for six months

OTHERWater

One litre a day for six months.

Sponsors

LG Life Sciences
CollaboratorINDUSTRY
Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 20-50 years; * BMI between 28-36 kg/m2; * Weight stabile 3 months prior to the study inclusion; * Less than 10 hours of weekly exercise

Exclusion criteria

* Diabetes * Allergic to phenylalanine or milk * Smoking * Pregnancy or breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Body Weight (kg)Six months
MR spectroscopySix monthsto assess liver fat and skeletal muscle fat
Magnetic resonance imagingSix monthsto assess visceral adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAAT)
Dual-energy X-ray absorptiometry (DEXA) scanSix monthsto assess total fat mass (kg), lean body mass (kg), and bone mass (kg)

Secondary

MeasureTime frameDescription
Oral Glucose Tolerance Test (OGTT)Six monthsAUC OGTT glucose and insulin, AUC HOMA-IR, and Matzuda index
Fasting blood lipidsSix monthsTotal, LDL, and HDL cholesterol, and TAG (mmol/L)
Blood pressureSix monthsSystolic and diastolic blood pressure (mmHg)
Fasting plasma PAI-1Six monthsng/ml
Fasting plasma FFASix monthsmmol/L
Circulating metabolic parameters: including serum urateSix monthsmmol/L
fasting plasma glucoseSix monthsmmol/L
fasting serum insulinSix monthspmol/L

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026